Related references
Note: Only part of the references are listed.Enzymes of the mevalonate pathway of isoprenoid biosynthesis
Henry M. Miziorko
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort
Eric J. Jacobs et al.
CANCER RESEARCH (2011)
What do the statin trials tell us?
David D. Waters
CLINICAL CARDIOLOGY (2010)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Statins Are Not Associated With a Reduced Risk of Pancreatic Cancer at the Population Level, When Taken at Low Doses for Managing Hypercholesterolemia: Evidence From a Meta-Analysis of 12 Studies
Stefanos Bonovas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Statins and cancer risk
Igor Karp et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Effects of statins on adipose tissue inflammation their inhibitory effect on MyD88-independent IRF3/IFN-β pathway in macrophages
Manabu Abe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Functional divergence between co-chaperones of Hsc70
Stefan Tzankov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Model-based variance-stabilizing transformation for Illumina microarray data
Simon M. Lin et al.
NUCLEIC ACIDS RESEARCH (2008)
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)
Bora Inceoglu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats
BS Reddy et al.
CANCER RESEARCH (2006)
Prelamin A and lamin A appear to be dispensable in the nuclear lamina
LG Fong et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A network-based analysis of systemic inflammation in humans
SE Calvano et al.
NATURE (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention
BS Reddy
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2004)
Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism
MA Shibata et al.
CARCINOGENESIS (2004)
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
MA Shibata et al.
CARCINOGENESIS (2003)
Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine
DN Seril et al.
CARCINOGENESIS (2002)
Limitations of a meta-analysis investigating the association between cancer and statin use
H Iwata et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Safety of HMG-CoA reductase inhibitors: Focus on atorvastatin
F Bernini et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Share Paper
